Chemoinformaics analysis of (Z)-14-tricosenyl formate
| Molecular Weight | 366.63 | nRot | 22 |
| Heavy Atom Molecular Weight | 320.262 | nRig | 2 |
| Exact Molecular Weight | 366.35 | nRing | 0 |
| Solubility: LogS | -3.618 | nHRing | 0 |
| Solubility: LogP | 9.06 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 72.3565 |
| nHD | 0 | BPOL | 48.7515 |
| QED | 0.11 |
| Synth | 2.331 |
| Natural Product Likeliness | 0.685 |
| NR-PPAR-gamma | 0.084 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.047 |
| CACO-2 | -5.109 |
| MDCK | 0.0000219 |
| BBB | 0.031 |
| PPB | 0.985154 |
| VDSS | 4.56 |
| FU | 0.0103712 |
| CYP1A2-inh | 0.113 |
| CYP1A2-sub | 0.162 |
| CYP2c19-inh | 0.257 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.072 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.443 |
| CYP2d6-sub | 0.132 |
| CYP3a4-inh | 0.263 |
| CYP3a4-sub | 0.038 |
| CL | 3.331 |
| T12 | 0.262 |
| hERG | 0.49 |
| Ames | 0.015 |
| ROA | 0.017 |
| SkinSen | 0.975 |
| Carcinogencity | 0.055 |
| EI | 0.932 |
| Respiratory | 0.9 |
| NR-Aromatase | 0.167 |
| Antiviral | No |
| Prediction | 0.567154 |